Active Biotech AB (publ) (STO:ACTI)
Sweden
· Delayed Price · Currency is SEK 0.0614
-0.0015 (-2.38%)
Apr 29, 2026, 2:08 PM CET
Active Biotech AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 65.1 | 27.4 | 36.22 | 41.8 | 53.13 | Upgrade
|
| Cash & Short-Term Investments | 65.1 | 27.4 | 36.22 | 41.8 | 53.13 | Upgrade
|
| Cash Growth | 137.63% | -24.36% | -13.35% | -21.34% | 102.70% | Upgrade
|
| Other Receivables | 1.4 | 9.5 | 1.26 | 0.95 | 1.19 | Upgrade
|
| Receivables | 1.4 | 9.5 | 1.26 | 0.95 | 1.19 | Upgrade
|
| Prepaid Expenses | 1.08 | 2.32 | 1.24 | 1.38 | 1.53 | Upgrade
|
| Total Current Assets | 67.58 | 39.21 | 38.71 | 44.12 | 55.86 | Upgrade
|
| Property, Plant & Equipment | 2.02 | 3.35 | 4.72 | 6.26 | 0.95 | Upgrade
|
| Other Intangible Assets | 0.25 | 0.25 | 0.25 | 0.25 | - | Upgrade
|
| Other Long-Term Assets | 0.38 | 0.38 | 0.38 | 0.38 | 0 | Upgrade
|
| Total Assets | 70.21 | 43.18 | 44.05 | 51.01 | 56.8 | Upgrade
|
| Accounts Payable | 4.92 | 1.45 | 3.17 | 3.53 | 2.76 | Upgrade
|
| Accrued Expenses | 7.68 | 5.44 | 5.36 | 6.37 | 5.98 | Upgrade
|
| Current Portion of Leases | 1.61 | 1.65 | 1.55 | 1.61 | 0.76 | Upgrade
|
| Other Current Liabilities | 0.28 | 0.36 | 0.3 | 0.56 | 0.41 | Upgrade
|
| Total Current Liabilities | 14.47 | 8.91 | 10.38 | 12.06 | 9.9 | Upgrade
|
| Long-Term Leases | 0.13 | 1.53 | 3 | 4.43 | 0.23 | Upgrade
|
| Total Liabilities | 14.6 | 10.44 | 13.38 | 16.49 | 10.13 | Upgrade
|
| Common Stock | 13.61 | 6.35 | 1.87 | 1.37 | 1.13 | Upgrade
|
| Additional Paid-In Capital | 3,562 | 3,509 | 3,472 | 3,431 | 3,386 | Upgrade
|
| Retained Earnings | -3,520 | -3,483 | -3,443 | -3,398 | -3,340 | Upgrade
|
| Shareholders' Equity | 55.61 | 32.74 | 30.67 | 34.51 | 46.67 | Upgrade
|
| Total Liabilities & Equity | 70.21 | 43.18 | 44.05 | 51.01 | 56.8 | Upgrade
|
| Total Debt | 1.74 | 3.18 | 4.55 | 6.04 | 0.99 | Upgrade
|
| Net Cash (Debt) | 63.36 | 24.21 | 31.67 | 35.76 | 52.15 | Upgrade
|
| Net Cash Growth | 161.72% | -23.56% | -11.42% | -31.43% | 115.38% | Upgrade
|
| Net Cash Per Share | 0.05 | 0.06 | 0.12 | 0.15 | 0.24 | Upgrade
|
| Filing Date Shares Outstanding | 2,636 | 1,230 | 361.74 | 264.89 | 217.97 | Upgrade
|
| Total Common Shares Outstanding | 2,636 | 1,066 | 361.74 | 264.89 | 217.97 | Upgrade
|
| Working Capital | 53.11 | 30.3 | 28.33 | 32.06 | 45.95 | Upgrade
|
| Book Value Per Share | 0.02 | 0.03 | 0.08 | 0.13 | 0.21 | Upgrade
|
| Tangible Book Value | 55.37 | 32.5 | 30.42 | 34.27 | 46.67 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.03 | 0.08 | 0.13 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.